Page last updated: 2024-10-17

aminocaproic acid and Age-Related Macular Degeneration

aminocaproic acid has been researched along with Age-Related Macular Degeneration in 1 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sharma, R1
George, A1
Nimmagadda, M1
Ortolan, D1
Karla, BS1
Qureshy, Z1
Bose, D1
Dejene, R1
Liang, G1
Wan, Q1
Chang, J1
Jha, BS1
Memon, O1
Miyagishima, KJ1
Rising, A1
Lal, M1
Hanson, E1
King, R1
Campos, MM1
Ferrer, M1
Amaral, J1
McGaughey, D1
Bharti, K1

Other Studies

1 other study available for aminocaproic acid and Age-Related Macular Degeneration

ArticleYear
Epithelial phenotype restoring drugs suppress macular degeneration phenotypes in an iPSC model.
    Nature communications, 2021, 12-15, Volume: 12, Issue:1

    Topics: Alleles; Aminocaproic Acid; Complement Factor H; Drug Evaluation, Preclinical; Humans; Induced Pluri

2021